A comprehensive view of Bayer AG. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.
Bayer AG Spearheads Life Sciences Innovation with AI-Driven R&D and Sustainability Initiatives, Accelerating Clinical Trials by 170,000 Hours
Published:
May 18, 2024
by Industry Intelligence Inc.
|
Bayer AG Advances Women's Health with Non-Hormonal Menopause Treatment Studies, Bolsters Sustainable Agriculture in India, and Supports Ukrainian Food Security Amidst Crisis
Published:
May 17, 2024
by Industry Intelligence Inc.
|
Bayer AG Advances Industry with Agricultural Support, Innovative Cancer Therapy Study, and Women's Health Vision
Published:
May 16, 2024
by Industry Intelligence Inc.
|
Bayer initiates Phase I clinical study of 225Ac-PSMA-Trillium, a next-generation targeted alpha therapy, for advanced metastatic prostate cancer; the dose-escalation study will evaluate safety, tolerability, and efficacy
Published:
May 15, 2024
by Bayer AG
|
Bayer AG Bolsters Women's Healthcare in Australia with $5.2M Training Support and Forges Strategic Alliance in Egypt to Enhance Healthcare Access
Published:
May 15, 2024
by Industry Intelligence Inc.
|
Ask us about our Consumer Wellness market view